skip to content
Race in a bottle : the story of BiDil and racialized medicine in a post-genomic age Preview this item
ClosePreview this item
Checking...

Race in a bottle : the story of BiDil and racialized medicine in a post-genomic age

Author: Jonathan Kahn
Publisher: New York : Columbia University Press, [2013]
Edition/Format:   Print book : EnglishView all editions and formats
Summary:
Approved by the FDA in 2005 as the first drug with a race-specific indication on its label, BiDil was touted as a pathbreaking therapy to treat heart failure in black patients. Kahn reveals that, at the most basic level, BiDil became racial through legal maneuvering and commercial pressure as much as through medical understandings of how the drug worked. He examines the legal and calls for a more reasoned approach  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: History
Document Type: Book
All Authors / Contributors: Jonathan Kahn
ISBN: 9780231162982 0231162987 0231531273 9780231531276 9780231162999 0231162995
OCLC Number: 794366478
Awards: Commended for Honorable Mention - Best Book Award, Race, Ethnicity, and Politics Section 2013
Description: xi, 311 pages ; 24 cm
Contents: Organizing race : paths toward the re-biologization of race in modern biomedical research, practice, and product development --
The birth of BiDil : how a drug becomes "ethnic" --
Statistical mischief and racial frames for drug development and marketing --
Capitalizing (on) race in drug development --
Race-ing patents/patenting race : an emerging political geography of intellectual property in biotechnology --
Not fade away : the persistence of race and the politics of the "meantime" in pharmacogenomics --
From disparity to difference : the politics of racial medicine.
Responsibility: Jonathan Kahn.

Abstract:

Approved by the FDA in 2005 as the first drug with a race-specific indication on its label, BiDil was touted as a pathbreaking therapy to treat heart failure in black patients. Kahn reveals that, at the most basic level, BiDil became racial through legal maneuvering and commercial pressure as much as through medical understandings of how the drug worked. He examines the legal and calls for a more reasoned approach to using race in biomedical research and practice.

Reviews

Editorial reviews

Publisher Synopsis

Jonathan Kahn's approach offers an airtight analysis of the commoditization of race in pharmaceutical development, and Race in a Bottle should be of interest and deep concern to numerous audiences. Read more...

 
User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/794366478> # Race in a bottle : the story of BiDil and racialized medicine in a post-genomic age
    a schema:Book, schema:CreativeWork ;
    library:oclcnum "794366478" ;
    library:placeOfPublication <http://id.loc.gov/vocabulary/countries/nyu> ;
    schema:about <http://experiment.worldcat.org/entity/work/data/1167704301#Topic/heart_failure_ethnology> ; # Heart Failure--ethnology
    schema:about <http://experiment.worldcat.org/entity/work/data/1167704301#Topic/pharmacogenetics_social_aspects> ; # Pharmacogenetics--Social aspects
    schema:about <http://dewey.info/class/616.12906108996073/e23/> ;
    schema:about <http://experiment.worldcat.org/entity/work/data/1167704301#Topic/heart_failure_drug_therapy> ; # Heart Failure--drug therapy
    schema:about <http://experiment.worldcat.org/entity/work/data/1167704301#Topic/african_americans> ; # African Americans
    schema:about <http://experiment.worldcat.org/entity/work/data/1167704301#Topic/isosorbide_dinitrate_therapeutic_use> ; # Isosorbide Dinitrate--therapeutic use
    schema:about <http://experiment.worldcat.org/entity/work/data/1167704301#Topic/pharmaceutical_industry_political_aspects_united_states> ; # Pharmaceutical industry--Political aspects--United States
    schema:about <http://experiment.worldcat.org/entity/work/data/1167704301#Place/united_states> ; # United States.
    schema:about <http://experiment.worldcat.org/entity/work/data/1167704301#Topic/hydralazine_therapeutic_use> ; # Hydralazine--therapeutic use
    schema:about <http://id.worldcat.org/fast/952806> ; # Health and race
    schema:about <http://experiment.worldcat.org/entity/work/data/1167704301#Topic/hydralazine_development_history> ; # Hydralazine--Development--History
    schema:about <http://id.worldcat.org/fast/1204155> ; # United States.
    schema:about <http://id.worldcat.org/fast/799638> ; # African Americans--Medical care
    schema:about <http://id.loc.gov/authorities/subjects/sh85001965> ; # African Americans--Medical care
    schema:about <http://experiment.worldcat.org/entity/work/data/1167704301#Topic/pharmacogenetics> ; # Pharmacogenetics
    schema:bookFormat bgn:PrintBook ;
    schema:creator <http://viaf.org/viaf/108027691> ; # Jonathan Kahn
    schema:datePublished "2013" ;
    schema:description "Approved by the FDA in 2005 as the first drug with a race-specific indication on its label, BiDil was touted as a pathbreaking therapy to treat heart failure in black patients. Kahn reveals that, at the most basic level, BiDil became racial through legal maneuvering and commercial pressure as much as through medical understandings of how the drug worked. He examines the legal and calls for a more reasoned approach to using race in biomedical research and practice."@en ;
    schema:description "Organizing race : paths toward the re-biologization of race in modern biomedical research, practice, and product development -- The birth of BiDil : how a drug becomes "ethnic" -- Statistical mischief and racial frames for drug development and marketing -- Capitalizing (on) race in drug development -- Race-ing patents/patenting race : an emerging political geography of intellectual property in biotechnology -- Not fade away : the persistence of race and the politics of the "meantime" in pharmacogenomics -- From disparity to difference : the politics of racial medicine."@en ;
    schema:exampleOfWork <http://worldcat.org/entity/work/id/1167704301> ;
    schema:genre "History"@en ;
    schema:inLanguage "en" ;
    schema:name "Race in a bottle : the story of BiDil and racialized medicine in a post-genomic age"@en ;
    schema:productID "794366478" ;
    schema:workExample <http://worldcat.org/isbn/9780231162999> ;
    schema:workExample <http://worldcat.org/isbn/9780231531276> ;
    schema:workExample <http://worldcat.org/isbn/9780231162982> ;
    wdrs:describedby <http://www.worldcat.org/title/-/oclc/794366478> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/1167704301#Place/united_states> # United States.
    a schema:Place ;
    schema:name "United States." ;
    .

<http://experiment.worldcat.org/entity/work/data/1167704301#Topic/african_americans> # African Americans
    a schema:Intangible ;
    schema:name "African Americans"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/1167704301#Topic/heart_failure_drug_therapy> # Heart Failure--drug therapy
    a schema:Intangible ;
    schema:name "Heart Failure--drug therapy"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/1167704301#Topic/heart_failure_ethnology> # Heart Failure--ethnology
    a schema:Intangible ;
    schema:name "Heart Failure--ethnology"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/1167704301#Topic/hydralazine_therapeutic_use> # Hydralazine--therapeutic use
    a schema:Intangible ;
    schema:name "Hydralazine--therapeutic use"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/1167704301#Topic/isosorbide_dinitrate_therapeutic_use> # Isosorbide Dinitrate--therapeutic use
    a schema:Intangible ;
    schema:name "Isosorbide Dinitrate--therapeutic use"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/1167704301#Topic/pharmaceutical_industry_political_aspects_united_states> # Pharmaceutical industry--Political aspects--United States
    a schema:Intangible ;
    schema:hasPart <http://id.loc.gov/authorities/subjects/sh85039713> ;
    schema:name "Pharmaceutical industry--Political aspects--United States"@en ;
    .

<http://id.loc.gov/authorities/subjects/sh85001965> # African Americans--Medical care
    a schema:Intangible ;
    schema:name "African Americans--Medical care"@en ;
    .

<http://id.worldcat.org/fast/1204155> # United States.
    a schema:Place ;
    schema:name "United States." ;
    .

<http://id.worldcat.org/fast/799638> # African Americans--Medical care
    a schema:Intangible ;
    schema:name "African Americans--Medical care"@en ;
    .

<http://id.worldcat.org/fast/952806> # Health and race
    a schema:Intangible ;
    schema:name "Health and race"@en ;
    .

<http://viaf.org/viaf/108027691> # Jonathan Kahn
    a schema:Person ;
    schema:familyName "Kahn" ;
    schema:givenName "Jonathan" ;
    schema:name "Jonathan Kahn" ;
    .

<http://worldcat.org/isbn/9780231162982>
    a schema:ProductModel ;
    schema:isbn "0231162987" ;
    schema:isbn "9780231162982" ;
    .

<http://worldcat.org/isbn/9780231162999>
    a schema:ProductModel ;
    schema:isbn "0231162995" ;
    schema:isbn "9780231162999" ;
    .

<http://worldcat.org/isbn/9780231531276>
    a schema:ProductModel ;
    schema:isbn "0231531273" ;
    schema:isbn "9780231531276" ;
    .

<http://www.worldcat.org/title/-/oclc/794366478>
    a genont:InformationResource, genont:ContentTypeGenericResource ;
    schema:about <http://www.worldcat.org/oclc/794366478> ; # Race in a bottle : the story of BiDil and racialized medicine in a post-genomic age
    schema:dateModified "2018-08-09" ;
    void:inDataset <http://purl.oclc.org/dataset/WorldCat> ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.